Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Construct Validity and Responsiveness of EQ-5D-3L in Patients With Rheumatic Disease

NCT06568029 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT06568029
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06568029 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Construct Validity and Responsiveness of EQ-5D-3L in Patients With Rheumatic Disease
Lead sponsor
Karolinska Institutet
Phase
Observational
Overall status
Completed
Start date
August 16, 2024
Completion date
September 30, 2024
Enrollment
77,651 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis, polyarthritis, psoriatic arthritis, rheumatic diseases, rheumatoid arthritis